Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
Celularity Inc. (CELU), a Delaware corporation, filed this Current Report on Form 8-K on December 23, 2025, regarding events occurring on December 19, 2025. The filing details the entry into material definitive agreements for a dual financing structure consisting of a Senior Secured Note Financing and a Convertible Note Financing with an accredited investor.
Key Financial Metrics and Capital Structure
The filing outlines the following capital raises and terms:
- Senior Secured Note: Initial principal of $7,000,000 with an option to sell up to an additional $1,400,000 (total potential $8,400,000) by June 19, 2026.
- Senior Note Interest: 4% per annum, increasing to 12% upon an Event of Default.
- Senior Note Maturity: April 30, 2026, or earlier upon a qualifying financing or strategic transaction.
- Senior Note Warrant: Covers 2,448,917 shares at an exercise price of $2.00 per share.
- Convertible Note: Initial principal of $3,000,000 with an option to purchase up to an additional $2,000,000 (total potential $5,000,000) within six months.
- Convertible Note Interest: 8% per annum, payable in kind, increasing to 12% upon an Event of Default.
- Convertible Note Maturity: December 31, 2026.
- Convertible Note Conversion: Conversion price of $1.66 per share.
- Convertible Note Warrant: Covers 1,258,740 shares at an exercise price of $2.00 per share.
The filing does not provide specific revenue, profit, cash flow, or liquidity metrics for the reporting period, as this is a transactional filing rather than a periodic financial report.
Material Changes and Agreements
The primary material change is the creation of new direct financial obligations and the issuance of unregistered equity securities. Key terms include:
- Security Interest: The Company granted a first-priority security interest over substantially all assets to secure the Senior Note and over proceeds from a qualified financing to secure the Convertible Note.
- Registration Rights: The Company agreed to file a registration statement for the warrants and convertible shares within 45 days of the effective date, with an effectiveness deadline of 90 to 120 days.
- Board Observer Rights: The Investor received the right to designate one non-voting observer to the Board of Directors, terminating if ownership falls below 5% or upon a Change of Control.
- Most Favored Nation: Investors have rights to receive more favorable terms if the Company enters into subsequent financings with other investors on better terms.
Outlook, Risks, and Contingencies
Management commentary is limited to the announcement of the financing closing. The filing highlights several risks and contingencies:
- Default Risk: Interest rates on both notes jump to 12% upon an Event of Default.
- Dilution: The Convertible Note includes a price protection mechanism; if the Company issues shares below the $1.66 conversion price, the conversion price will be reduced.
- Liquidity Constraints: The Senior Note matures early if the Company consummates a financing or strategic transaction with proceeds equal to or greater than the outstanding principal.
- Regulatory Status: The securities were issued under Section 4(a)(2) and Regulation D exemptions and are not registered under the Securities Act.
Investor Verification Checklist
- Verify the total cash proceeds received from the $10,000,000 initial principal ($7M Senior + $3M Convertible) and confirm the closing date of December 22, 2025.
- Review the "Event of Default" definitions in the attached exhibits to understand triggers for the 12% penalty interest rate.
- Monitor the Company's ability to file the required registration statement within 45 days to ensure liquidity for the warrant holders.
- Assess the impact of the first-priority security interest on substantially all assets on future borrowing capacity.
- Track the Company's stock price relative to the $1.66 conversion price and $2.00 warrant exercise price to evaluate potential dilution.